Botswana vs Chile: Prevalence of current tobacco use, males
Prevalence of current tobacco use, males over time
- Botswana
- Chile
How they compare
Botswana currently reports 29.4% against 29.2% in Chile, a difference of 0.2%.
The two have swapped places 1 time across 9 shared years of data; in 2000 it was Chile ahead.
Botswana ranks 77th and Chile ranks 78th of 166 countries.
Chile has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Botswana | Chile | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 38.2% | 46.3% | 8.1% | Chile |
| 2010s | 34.0% | 38.0% | 4.0% | Chile |
| 2020s | 30.1% | 30.4% | 0.3% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of current tobacco use, males, Botswana or Chile?
- Botswana, at 29.4% against 29.2% in Chile as of 2024.
- What is the difference in prevalence of current tobacco use, males between Botswana and Chile?
- 0.2%, with Botswana ahead.
- How many years of comparable data are there for Botswana and Chile?
- 9 years are reported by both, from 2000 to 2024.
- How do Botswana and Chile rank globally for prevalence of current tobacco use, males?
- Botswana ranks 77th and Chile ranks 78th of 166 countries.
- Where does this data come from?
- Global Health Observatory Data Repository, World Health Organization (WHO), published as Prevalence of current tobacco use, males (% of male adults). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of the male population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.